The Use of Midazolam and Remifentanil During Dialysis Access Procedures
Status:
Completed
Trial end date:
2016-04-30
Target enrollment:
Participant gender:
Summary
BACKGROUND: Sedation and analgesia are related to unexpected adverse events in chronic renal
failure patients undergoing arteriovenous fistula placement procedures under monitored
anesthesia care (MAC).
OBJECTIVE: Our goal was to investigate and compare the sedation and analgesia related effects
and adverse effects of continuous intravenous use of midazolam and intermittent bolus doses
of midazolam while intravenous remifentanil is used as a rescue medication in patients with
chronic renal failure.
Phase:
N/A
Details
Lead Sponsor:
Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital